Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01502995 · ClinicalTrials.gov registry record · Phase 3
Laser Light Visual Cueing for Freezing of Gait in Parkinson's Disease
A Phase 3 study, sponsored by Parkinson's Disease Research, Education, and Clinical Center, Philadelphia.
- Completed
- Registry status
- Phase 3
- Development phase
- 22
- Enrollment target
NCT01502995: Completed Phase 3 study, sponsored by Parkinson's Disease Research, Education, and Clinical Center, Philadelphia.
NCT01502995 is a Phase 3 study that has completed, run by Parkinson's Disease Research, Education, and Clinical Center, Philadelphia. The registered enrollment target is 22 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01502995, a Phase 3 study, has completed, sponsored by Parkinson's Disease Research, Education, and Clinical Center, Philadelphia.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a laser light beam, attached to a rolling walker and projected onto the floor, reduces freezing episodes in patients with Parkinson's disease.
Primary Outcome
Time in seconds for subject to complete the designated walking task.
Interventions
- DEVICE Laser light (U-Step Walking Stabilizer with laser light)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2003-06 |
| Est. Completion | 2005-04 |
| Phase | Phase 3 |
What the finished NCT01502995 record still lists
NCT01502995 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Laser light (U-Step Walking Stabilizer with laser light) is the first listed.
NCT01502995 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01502995 about?
NCT01502995 is a clinical study titled "Laser Light Visual Cueing for Freezing of Gait in Parkinson's Disease". The purpose of this study is to determine whether a laser light beam, attached to a rolling walker and projected onto the floor, reduces freezing episodes in patients with Parkinson's disease.
What is the current status of trial NCT01502995?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 22 participants. The study started on 2003-06. Estimated completion is 2005-04.
What interventions are being tested in trial NCT01502995?
The interventions under investigation include: Laser light (U-Step Walking Stabilizer with laser light) (DEVICE).
Who is sponsoring clinical trial NCT01502995?
This trial is sponsored by Parkinson's Disease Research, Education, and Clinical Center, Philadelphia, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01502995's enrollment target sits among peer trials
22 1953rd of 2000 higher than 48 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia